Reviva Pharmaceuticals Holdings, Inc. SEC filings RVPH

Reviva Pharmaceuticals Holdings, Inc. has 413 filings in SEC EDGAR's recent list, going back to Jun 19, 2018. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Reviva Pharmaceuticals Holdings, Inc. SEC filings
Form Description Filed Period
PRE 14A Preliminary proxy statement Oct 29, 2026 Dec 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 12, 2026 Aug 12, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 3, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 31, 2026 —
25-NSE Delisting notice Jul 10, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 14, 2026 —
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 13, 2026 May 13, 2026
8-K Current report
Listing notice, Other events
May 13, 2026 May 12, 2026
SCHEDULE 13G Ownership over 5% (passive) May 7, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Apr 15, 2026 Apr 15, 2026
SCHEDULE 13G Ownership over 5% (passive) Mar 30, 2026 —
S-8 Employee stock plan registration Mar 30, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure
Mar 30, 2026 Mar 30, 2026
10-K Annual report Mar 30, 2026 Dec 31, 2025
SCHEDULE 13G Ownership over 5% (passive) Mar 25, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 24, 2026 —
4 Insider transaction Mar 20, 2026 Mar 18, 2026
4 Insider transaction Mar 20, 2026 Mar 18, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Mar 19, 2026 Mar 18, 2026
424B5 Prospectus supplement Mar 19, 2026 —
424B5 Prospectus supplement Mar 18, 2026 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Mar 5, 2026 Mar 4, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
8-K Current report
Listing notice, Other events
Jan 23, 2026 Jan 20, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 16, 2026 —
8-K Current report
Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure, Other events
Dec 23, 2025 Dec 18, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 22, 2025 —
4 Insider transaction Dec 19, 2025 Dec 18, 2025
4 Insider transaction Dec 19, 2025 Dec 18, 2025
4 Insider transaction Dec 19, 2025 Dec 18, 2025
4 Insider transaction Dec 19, 2025 Dec 18, 2025
25-NSE Delisting notice Dec 12, 2025 —
DEFA14A Additional proxy material Dec 5, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
Nov 13, 2025 Nov 13, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
ARS Annual report to shareholders Nov 4, 2025 Dec 31, 2024
DEFA14A Additional proxy material Nov 4, 2025 —
DEF 14A Proxy statement Nov 4, 2025 Dec 18, 2025
PRE 14A Preliminary proxy statement Oct 24, 2025 Dec 18, 2025
8-K Current report
Listing notice
Oct 17, 2025 Oct 14, 2025
SCHEDULE 13G Ownership over 5% (passive) Sep 29, 2025 —
8-K Current report
Bylaw or fiscal year change
Sep 26, 2025 Sep 26, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 24, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 24, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
Sep 19, 2025 Sep 18, 2025
424B5 Prospectus supplement Sep 19, 2025 —
424B5 Prospectus supplement Sep 18, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
Aug 14, 2025 Aug 14, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 1, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 1, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jul 1, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
Jun 26, 2025 Jun 26, 2025
424B5 Prospectus supplement Jun 26, 2025 —
424B5 Prospectus supplement Jun 25, 2025 —
8-K Current report
Auditor change
Jun 6, 2025 Jun 3, 2025
8-K Current report
Regulation FD disclosure, Other events
Jun 2, 2025 Jun 2, 2025
424B5 Prospectus supplement May 30, 2025 —
8-K Current report
Material agreement
May 30, 2025 May 30, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
May 15, 2025 May 15, 2025
S-8 Employee stock plan registration Apr 3, 2025 —
10-K Annual report Apr 3, 2025 Dec 31, 2024
NT 10-K Form nt 10-k Mar 31, 2025 Dec 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Mar 31, 2025 Mar 31, 2025
8-K Current report
Officer or director change
Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 7, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 31, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Dec 23, 2024 —
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 20, 2024 —
424B5 Prospectus supplement Dec 18, 2024 —
8-K Current report
Material agreement, Regulation FD disclosure
Dec 18, 2024 Dec 16, 2024
424B5 Prospectus supplement Dec 16, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Dec 16, 2024 Dec 16, 2024
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Dec 12, 2024 Dec 10, 2024
4 Insider transaction Dec 12, 2024 Dec 10, 2024
4 Insider transaction Dec 12, 2024 Dec 10, 2024
4 Insider transaction Dec 12, 2024 Dec 10, 2024
4 Insider transaction Dec 12, 2024 Dec 10, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Nov 14, 2024 Nov 14, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Nov 12, 2024 Nov 12, 2024
ARS Annual report to shareholders Oct 28, 2024 Dec 31, 2023
DEF 14A Proxy statement Oct 28, 2024 Dec 10, 2024
PRE 14A Preliminary proxy statement Oct 17, 2024 Dec 10, 2024
8-K Current report
Officer or director change
Sep 17, 2024 Sep 15, 2024
4 Insider transaction Sep 17, 2024 Sep 15, 2024
4 Insider transaction Sep 17, 2024 Sep 15, 2024
SC 13D/A Amended ownership over 5% (active) Aug 23, 2024 —
SC 13D/A Amended ownership over 5% (active) Aug 23, 2024 —
8-K/A Amended current report
Material agreement, Regulation FD disclosure
Aug 22, 2024 Aug 20, 2024
UPLOAD Letter from the SEC Aug 22, 2024 —
424B5 Prospectus supplement Aug 22, 2024 —
8-K Current report
Material agreement, Regulation FD disclosure
Aug 21, 2024 Aug 20, 2024
SC 13G Ownership over 5% (passive) Aug 14, 2024 —
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 14, 2024 Aug 14, 2024
CORRESP Letter to the SEC Aug 7, 2024 —
UPLOAD Letter from the SEC Jul 24, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Jul 9, 2024 Jul 9, 2024
SC 13D/A Amended ownership over 5% (active) May 31, 2024 —
8-K Current report
Material agreement
May 29, 2024 May 28, 2024
424B5 Prospectus supplement May 29, 2024 —
S-8 Employee stock plan registration May 17, 2024 —
8-K Current report
Regulation FD disclosure, Other events
May 15, 2024 May 15, 2024
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
May 14, 2024 May 14, 2024
8-K Current report
Regulation FD disclosure, Other events
Apr 15, 2024 Apr 15, 2024
10-K Annual report Apr 15, 2024 Dec 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Apr 15, 2024 Apr 15, 2024
8-K Current report
Results of operations, Restatement
Apr 15, 2024 Apr 12, 2024
NT 10-K Form nt 10-k Apr 2, 2024 Dec 31, 2023
SC 13D/A Amended ownership over 5% (active) Feb 16, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
EFFECT Filing Feb 13, 2024 —
424B4 Prospectus Feb 13, 2024 —
UPLOAD Letter from the SEC Feb 9, 2024 —
CORRESP Letter to the SEC Feb 9, 2024 —
S-3 Shelf registration Feb 2, 2024 —
SC 13D/A Amended ownership over 5% (active) Nov 30, 2023 —
4 Insider transaction Nov 22, 2023 Nov 20, 2023
8-K Current report
Material agreement
Nov 17, 2023 Nov 15, 2023
424B5 Prospectus supplement Nov 17, 2023 —
4 Insider transaction Nov 14, 2023 Nov 13, 2023
4 Insider transaction Nov 14, 2023 Nov 13, 2023
4 Insider transaction Nov 14, 2023 Nov 13, 2023
4 Insider transaction Nov 14, 2023 Nov 13, 2023
8-K Current report
Shareholder vote results
Nov 14, 2023 Nov 13, 2023
8-K/A Amended current report
Auditor change
Nov 14, 2023 Oct 4, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Nov 14, 2023 Nov 14, 2023
8-K Current report
Regulation FD disclosure, Other events
Oct 30, 2023 Oct 30, 2023
ARS Annual report to shareholders Oct 4, 2023 Dec 31, 2022
DEF 14A Proxy statement Oct 4, 2023 Nov 13, 2023
8-K Current report
Auditor change
Oct 4, 2023 Oct 4, 2023
8-K Current report
Regulation FD disclosure, Other events
Aug 17, 2023 Aug 17, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Aug 14, 2023 Aug 14, 2023
8-K Current report
Auditor change
Jul 24, 2023 Jul 18, 2023
8-K Current report
Regulation FD disclosure, Other events
Jun 23, 2023 Jun 22, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
May 15, 2023 May 15, 2023
SC 13D/A Amended ownership over 5% (active) May 5, 2023 —
4 Insider transaction Apr 27, 2023 Apr 25, 2023
8-K Current report
Officer or director change
Apr 27, 2023 Apr 25, 2023
4 Insider transaction Apr 27, 2023 Apr 25, 2023
424B3 Prospectus Apr 5, 2023 —
EFFECT Filing Apr 4, 2023 —
S-8 Employee stock plan registration Mar 30, 2023 —
POS AM Form pos am Mar 30, 2023 —
10-K Annual report Mar 30, 2023 Dec 31, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Mar 30, 2023 Mar 30, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
8-K Current report
Regulation FD disclosure
Jan 4, 2023 Jan 4, 2023
4 Insider transaction Nov 21, 2022 Nov 18, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Nov 14, 2022 Nov 14, 2022
4 Insider transaction Nov 14, 2022 Nov 10, 2022
4 Insider transaction Nov 14, 2022 Nov 10, 2022
4 Insider transaction Nov 14, 2022 Nov 10, 2022
8-K Current report
Shareholder vote results
Nov 14, 2022 Nov 10, 2022
4 Insider transaction Nov 14, 2022 Nov 10, 2022
424B4 Prospectus Oct 18, 2022 —
EFFECT Filing Oct 17, 2022 —
CORRESP Letter to the SEC Oct 13, 2022 —
UPLOAD Letter from the SEC Oct 12, 2022 —
DEF 14A Proxy statement Oct 11, 2022 Nov 10, 2022
S-1 Registration statement Oct 6, 2022 —
4 Insider transaction Oct 3, 2022 Sep 30, 2022
D Filing Sep 19, 2022 —
SC 13D/A Amended ownership over 5% (active) Sep 12, 2022 —
4 Insider transaction Sep 12, 2022 Sep 8, 2022
8-K Current report
Material agreement, Unregistered share sale
Sep 7, 2022 Sep 6, 2022
424B5 Prospectus supplement Sep 7, 2022 —
8-K Current report
Results of operations, Regulation FD disclosure
Aug 15, 2022 Aug 15, 2022
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
8-K Current report
Agreement ended
Jul 28, 2022 Jul 28, 2022
8-K Current report
Regulation FD disclosure, Other events
Jul 27, 2022 Jul 27, 2022
4 Insider transaction Jun 30, 2022 Jun 30, 2022
8-K Current report
Officer or director change
Jun 27, 2022 Jun 23, 2022
10-Q Quarterly report May 16, 2022 Mar 31, 2022
8-K Current report
Results of operations, Regulation FD disclosure
May 16, 2022 May 16, 2022
424B3 Prospectus Mar 23, 2022 —
424B3 Prospectus Mar 23, 2022 —
EFFECT Filing Mar 22, 2022 —
EFFECT Filing Mar 22, 2022 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RVPH (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cupertino, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1742927
Former names
Tenzing Acquisition Corp. (until Dec 14, 2020)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.